Skip to Main Content
Services Talent Knowledge
Site Search
Menu

News

July 27, 2020

Linda Clark and Brad Gallagher Published on Pharmacy Insider Blog

Linda Clark, Health Care Controversies Team leader, and Brad Gallagher, counsel, recently had their “Caremark’s Bold Move to Restrict Dispensing and Access to Products on the Formulary” article published on the Pharmacy Insider blog.

“Suspect product” lists have been used for years by pharmacy benefit managers (PBMs) to target independent pharmacies and subject them to heightened scrutiny. These lists often target high margin products or other drugs that, for other unknown reasons, may be disfavored by PBMs without regard to formularies of individual plans. The lists are secret, and only “word-of-mouth” through the experiences of other network pharmacies do we learn of the targeted products or manufacturers.”

Read the full article here.

Featured Media

Alerts

New York Public Service Commission Determines to Withdraw Its Finding in the New York City Offshore Wind Public Policy Transmission Need Process

Alerts

A "Sticky" Situation – Can Treatment of Administrative Claims Be Modified in a Subchapter V Plan?

Alerts

Key Affordable-Housing Provisions in the One Big Beautiful Bill Act

Alerts

What the One Big Beautiful Bill Act Means for Clean-Energy Tax Credits

Alerts

One Big Beautiful Bill Act Changes Tax Incentives for Charitable Giving

Alerts

Website Accessibility Lawsuits: Several "Tester" Plaintiffs—Wislande Claude, Felipe Fernandez, Howard Wilson, Lisa Cantwell, and Erika Alexandria—Targeting Businesses in Recent Flurry of Lawsuits